Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Narayanasamy Krishnasamy"'
Autor:
Alexander, Vijay, Kumar, Santhosh E., Chellaiya, Gayathiri Kaduvetti, Veetil, Deepthi Raran, Gnanadeepam, Sunderraj, Jayaraman, Sumathy, Abhilash, Kundavaram Paul Prabhakar, Adhikary, Debasis Das, Pichamuthu, Kishore, Jacob, Ebor, Kandasami, Subramani, Agarwal, Indira, David, Vinoi, Varughese, Santosh, Daniel, Dolly, Goel, Ashish, Zachariah, Uday, Eapen, Chundamannil Eapen, Satish, Shilpa Prabhakar, Narayanasamy, Krishnasamy, Sambandam, Maruthu Thurai, Raghunanthan, Srinivasan, Johnson, Jeyalydia, Mangaiyarkarasi, Amirthalingam, Paranthakan, Chellian, Narayanan, Suresh, Chandrasekar, Selvaraj, Sureshkanna, Singaram, Dhus, Ubal, Venkatraman, Jayanthi
Publikováno v:
In The Lancet Regional Health - Southeast Asia June 2024 25
Autor:
Anuradha Kandasamy, Narayanasamy Krishnasamy, Jayanthi Rangarajan, Gomathi Manju, Radhika Venugopal, Arunkumar Ramachandran, Karthick Rajendran
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 13, Iss 12, Pp DC10-DC14 (2019)
Introduction: Cirrhosis-Associated Immune Dysfunction (CAID) increases the risk of development of infection which progresses to sepsis and death. Most common infection associated with liver cirrhosis patients are Spontaneous Bacterial Peritonitis (SB
Externí odkaz:
https://doaj.org/article/23e4ba4a68f840f08007efd263dee1d0
Autor:
Malarvizhi, Murugesan, Ramkumar, Govindarajan, Lakshmi, Prakash, Chandra Kumar, Murugan, J Janifer, Jasmine, Narayanasamy, Krishnasamy
Publikováno v:
Euroasian Journal of Hepato-Gastroenterology. 12:24-30
This study aimed to assess the demographic details of coronavirus disease-2019 (COVID-19) patients, their comorbid conditions, preexisting illnesses such as tuberculosis (TB), the prevalence of gastrointestinal (GI) symptoms, duration of GI symptoms,
Autor:
Selvavinayagam, Sivaprakasam T., Yong, Yean Kong, Joseph, Narcisse, Hemashree, Kannan, Tan, Hong Yien, Zhang, Ying, Rajeshkumar, Manivannan, Kumaresan, Anandhazhvar, Kalpana, Raghu, Kalaivani, Vasudevan, Monika, Ayyagari Venkata Devi, Suvaithenamudhan, Suvaiyarasan, Kannan, Meganathan, Murugesan, Amudhan, Narayanasamy, Krishnasamy, Palani, Sampath, Larsson, Marie, Shankar, Esaki M., Raju, Sivadoss
Publikováno v:
Frontiers in Public Health. 10
The rapid spread of SARS-CoV-2 variants in the global population is indicative of the development of selective advantages in emerging virus strains. Here, we performed a case-control investigation of the clinical and demographic characteristics, clin
Autor:
Karthick Rajendran, Narayanasamy Krishnasamy, Priyadarshini Panneerselvam, Parimita Barua, Muthukumaran Rajaram, Arunkumar Ramachandran
Publikováno v:
Journal of Clinical and Translational Hepatology. 10:120-127
Background and Aims: Liver enzyme abnormalities in coronavirus 2019 (COVID-19) are being addressed in the literature. The predictive risk of elevated liver enzymes has not been established for COVID-19 mortality. In this study, we hypothesized that e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karthick Rajendran, Naganath babu obla lakshmanamoorthy, Narayanasamy Krishnasamy, Geetha Devadas, Theranirajan Etherajan, Babu Peter Sathyanathan, Arul Velusamy, Muthukumaran Rajaram, Anuradha Kandasamy, Mohan Panjacharam, Jayanthi Rengarajan, Mohammed Iliyas Rahamathula, Priyadarshini Panneerselvam, Ramesh Ramamoorthy, Meenakshi Shanmugasundaram, Jeromie Wesley Vivian Thangaraj, Murugan Natarajan, Poonguzhali Rajaji, Prabhuraman Kanagaraman, Arunkumar Ramachandran
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Globally, India has reported the third highest number of COVID-19 cases. Chennai, the capital of Tamil Nadu state, witnessed a huge surge in COVID-19 cases, resulting in the establishment of isolation facilities named COVID Care Center (CCC). In our
Autor:
Karthick Rajendran, Narayanasamy Krishnasamy, Arunkumar Ramachandran, Murugan Natarajan, Jayanthi Rangarajan, Jeyalalitha Rathinam
Publikováno v:
Journal of Medical Virology
The recent emergence of coronavirus disease 2019 (COVID‐19) pandemic has reassessed the usefulness of historic convalescent plasma transfusion (CPT). This review was conducted to evaluate the effectiveness of CPT therapy in COVID‐19 patients base
Publikováno v:
Annals of Pathology and Laboratory Medicine. 7:C6-9
Benign recurrent intrahepatic cholestasis (BRIC) is an inherited self limiting cholestatic disorder. It is very rare and less common than its severe form, Progressive familial intrahepatic cholestasis (PFIC). Due to impaired canalicular biliary excre
Autor:
K., Premkumar1, Narayanasamy, Krishnasamy2 drkns_1963@yahoo.com
Publikováno v:
International Archives of Integrated Medicine. 2019, Vol. 6 Issue 4, p49-54. 6p.